The FDA has approved nivolumab plus chemotherapy as a neoadjuvant treatment for operable stage IIA to IIIB non–small cell ...

The checkpoint inhibitor is now approved, based on CheckMate 77T findings, for neoadjuvant/adjuvant use in patients with resectable NSCLC.

The approval was based on data from the randomized, double-blind, placebo-controlled, phase 3 CheckMate -77T trial.

No benefit seen for rechallenge with nivolumab after progression in the post-immune checkpoint inhibitor setting.

When cancer cells mutate, they produce small peptides called neoantigens.  Because neoantigens remain relatively unique to ...

Illumina, Inc. , a global leader in DNA sequencing and array-based technologies, announced that after 11 years of service, Charles "Chuck" Dadswell will step down as General Counsel and Secretary on ...

Bristol-Myers Squibb (BMY) wins FDA nod to expand the U.S. label for its blockbuster immunotherapy Opdivo in lung cancer.

Sun Life U.S. and DentaQuest, part of Sun Life U.S., are supporting relief efforts in the states most severely impacted by Hurricane Helene. The support will go to multiple organizations, including ...

The Food and Drug Administration has approved Opdivo before and after surgery for some with non-small cell lung cancer.

North America Cancer Immunotherapy Market is expanding rapidly due to expanding approval of immunotherapeutic drugs for the treatment of increasing incidences of cancer and increasing investments in ...

US Vice president Kamala Harris targets dissatisfied Republicans by visiting the birthplace of the GOP in Ripon, Wisconsin, accompanied by former Representative Liz Cheney, a vocal Trump critic.

Elon Musk is having trouble distancing himself from questions over which of Sean “Diddy” Combs’ powerful friends and business associates possibly enabled his alleged “criminal enterprise,” which autho ...